New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not associated with more severe reactions during oral food ...
Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...
Opinion
News-Medical.Net on MSNOpinion
Study on inhaler overuse highlights urgent need for better objective asthma monitoring
Bedfont ® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced ...
Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...
More than 75% of adults in a virtual asthma self-management education program had improved asthma control afterward, according to data presented at the American Academy of Allergy, Asthma & Immunology ...
New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not ...
WTVC NewsChannel 9 on MSN
Asthma cases rising in Hamilton County: What’s triggering the spike?
AROUND 2 MILLION PEOPLE IN THE U.S. ARE LIVING WITH SEVERE ASTHMA.WITH THE SEASON CHANGING AND DIFFERENT WEATHER PATTERNS ON ...
Sometimes the story can be told in statistics. India accounts for 13% of the global population, yet it accounts for 42% of global asthma mortality. Around 35 million Indians are thought to be living ...
Wellbeing Magazine on MSN
Practical tips for ladies: Managing asthma symptoms with respiratory relief
Living with asthma presents unique challenges for women of all ages. Managing daily tasks requires a clear plan to keep your breathing steady and comfortable. Small changes in your daily routine make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results